Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,198,185
+$14,112 QoQ
Shares Held
20,407
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#337
of 1,603 holders
Holding Since
Dec 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $121,589,141 across 15 Drug Manufacturers - General names. NVS ranks #10 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,075 | $34,873,430 | |
| 2 | JNJ |
Johnson & Johnson
|
102,279 | $25,975,797 | |
| 3 | ABBV |
AbbVie Inc.
|
66,840 | $16,819,617 | |
| 4 | MRK |
Merck & Co., Inc.
|
84,812 | $10,898,342 | |
| 5 | AMGN |
Amgen Inc
|
16,519 | $5,981,860 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
43,955 | $5,553,274 | |
| 7 | PFE |
Pfizer Inc
|
209,089 | $5,034,863 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
71,425 | $4,115,508 |
All Filings in NVS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,198,185 | 20,407 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,184,073 | 20,845 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $536,038 | 3,888 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $904,989 | 7,057 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $793,462 | 6,557 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $709,012 | 6,360 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $562,451 | 5,780 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $595,458 | 5,177 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $591,172 | 5,553 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $444,667 | 4,597 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $436,493 | 4,323 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $370,566 | 3,638 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $429,977 | 4,261 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $326,140 | 3,545 | Shares | Sole | 2023-05-04 | |
| 2021-12-31 | $301,334 | 3,445 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||